The toll-like receptor agonist imiquimod is active against prions.
Using a yeast-based assay, a previously unsuspected antiprion activity was found for imiquimod (IQ), a potent Toll-like receptor 7 (TLR7) agonist already used for clinical applications. The antiprion activity of IQ was first detected against yeast prions [PSI (+) ] and [URE3], and then against mamma...
Main Authors: | Nassima Oumata, Phu Hai Nguyen, Vincent Beringue, Flavie Soubigou, Yanhong Pang, Nathalie Desban, Catherine Massacrier, Yannis Morel, Carine Paturel, Marie-Astrid Contesse, Serge Bouaziz, Suparna Sanyal, Hervé Galons, Marc Blondel, Cécile Voisset |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3745460?pdf=render |
Similar Items
-
Antihypertensive drug guanabenz is active in vivo against both yeast and mammalian prions.
by: Déborah Tribouillard-Tanvier, et al.
Published: (2008-04-01) -
Ribosomal RNA Modulates Aggregation of the <i>Podospora</i> Prion Protein HET-s
by: Yanhong Pang, et al.
Published: (2020-09-01) -
A yeast-based assay identifies drugs that interfere with immune evasion of the Epstein-Barr virus
by: Cécile Voisset, et al.
Published: (2014-04-01) -
p53, A Victim of the Prion Fashion
by: Olivier Billant, et al.
Published: (2021-01-01) -
A Simple Isomerization of the Purine Scaffold of a Kinase Inhibitor, Roscovitine, Affords a Four- to Seven-Fold Enhancement of Its Affinity for Four CDKs. Could This Be Traced Back to Conjugation-Induced Stiffenings/Loosenings of Rotational Barriers?
by: Krystel El Hage, et al.
Published: (2017-07-01)